Navigation Links
Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
Date:3/20/2008

y alloy means the discovery can quickly be applied to a range of uses, leading to higher cooling and power generation efficiency.

By using nanotechnology, we have found a way to improve an old material by breaking it up and then rebuilding it in a composite of nanostructures in bulk form, said Boston College physicist Zhifeng Ren, one of the leaders of the project. This method is low cost and can be scaled for mass production. This represents an exciting opportunity to improve the performance of thermoelectric materials in a cost-effective manner.

These thermoelectric materials are already used in many applications, but this better material can have a bigger impact, said Gang Chen, the Warren and Towneley Rohsenow Professor of Mechanical Engineering at MIT and another leader of the project.

At its core, thermoelectricity is the hot and cool issue of physics. Heating one end of a wire, for example, causes electrons to move to the cooler end, producing an electric current. In reverse, applying a current to the same wire will carry heat away from a hot section to a cool section. Phonons, a quantum mode of vibration, play a key role because they are the primary means by which heat conduction takes place in insulating solids.

Bismuth antimony telluride is a material commonly used in thermoelectric products, and the researchers crushed it into a nanoscopic dust and then reconstituted it in bulk form, albeit with nanoscale constituents. The grains and irregularities of the reconstituted alloy dramatically slowed the passage of phonons through the material, radically transforming the thermoelectric performance by blocking heat flow while allowing the electrical flow.

In addition to Ren and six researchers at his BC lab, the international team involved MIT researchers, including Chen and Institute Professor Mildred S. Dresselhaus; research scientist Bed Poudel at GMZ Energy, Inc, a Newton, Mass.-based company formed by Ren, Chen,
'/>"/>

Contact: Ed Hayward
ed.hayward@bc.edu
617-552-4826
Boston College
Source:Eurekalert  

Page: 1 2 3

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine”) ... company, today announced that the U.S. Food and ... Track designation and Phase I clinical trials of ... the mutual co-development agreement signed with Gilead Life ... designation for the DPX-Survivac. , “We have been ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
(Date:2/26/2015)... 26, 2015 S&P Capital IQ (MHFI) announced ... coverage on MabVax Therapeutics Holdings Inc . ... stage biotechnology company focused on the development of vaccine ... the treatment of cancer. MabVax has discovered a pipeline ... immune responses generated by patients who have been immunized ...
(Date:2/26/2015)... 26, 2015   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today reported ... goals, other key objectives, and financial guidance.  Synageva,s ... at 4:30 p.m. EST to review the financial ... participate in today,s call by telephone, please dial ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... Inc.,(Nasdaq: ENMD ), a clinical-stage pharmaceutical ... and inflammatory diseases, today,announced that the U.S. ... its,Investigational New Drug (IND) application for its ... ), ENMD-2076 is a novel, ...
... Cinpathogen, through its,partnership in the Fudan-Cinpathogen Clinical and ... consulting,services to Shanghai area hospitals. For the past ... the Center has diagnosed and characterized over 3000,cases ... area,hospitals and colleagues at Fudan University, the University ...
... N.C., Jan. 3 Chimerix, Inc., a,biotechnology company ... Frazer, M.B., Ch.B., FRCA, FFPM has joined the,company ... Chimerix, Dr. Frazer served as the Chief Medical,Officer ... Medical) where he was responsible for the design ...
Cached Biology Technology:EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076 2EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076 3Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals 2Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer 2
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
(Date:1/22/2015)... , Jan. 13, 2015 Technology Showcase, Hall E ... identity authentication solutions, today announced it will showcase its EyeLock ... developed by the Department of Energy,s Oak Ridge National ... Auto Show . EyeLock,s iris identity authentication technology is being ...
(Date:1/22/2015)... Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication company ... of the Wocket™ smart wallet at CES 2015 in Las ... one of the "11 Hot Products at CES" in a review published ... Far" by Newseveryday.com and "The top 10 gadgets from CES 2015" by ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... head impact injury are an interesting scientific question. Professor ... for Biomechanics and Mechanobiology of the Ministry of Education, ... and the School of Materials Science and Engineering, Wuhan ... After 3 years of innovative research, they are making ...
... to achieve goals set by the federal government for reducing ... need to eliminate an average of 64 excess calories per ... American Journal of Preventive Medicine . This reduction could ... both. Without this reduction, the authors predict that the average ...
... Ill. -- Researchers have determined that bacteria are present ... the common belief that normal urine is sterile. These ... Journal of Clinical Microbiology by researchers at ... "Doctors have been trained to believe that urine is ...
Cached Biology News:Mechanical properties and microstructure of cranial and beak bones of the woodpecker and the lark 2How many calories does it take to reach childhood obesity prevention goals? 2How many calories does it take to reach childhood obesity prevention goals? 3Loyola study debunks common myth that urine is sterile 2
Concentration: 1mg/ml. Antigen: Propidium Iodide ...
Anti-Mouse Qa.m7, Ascites (Clone 5035-50.1) (mouse IgM)...
Barcoded Slides, 5 Packs of 5 Slides (25/Case)...
Anti-Mouse Qa.m8, Ascites (Clone 5035-24.1) (mouse IgG3)...
Biology Products: